QualityStocks

[QualityStocks]

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) President and CEO Discusses Recent Company Activities in Interview on Uptick Newswire’s “Stock Day” Podcast

Global life sciences company Pressure BioSciences Inc.’s (OTCQB: PBIO) president and CEO Richard T. Schumacher was recently interviewed on Uptick Newswire’s “Stock Day” podcast. Among other highlights of the interview, Schumacher discussed the company’s sustained financial success, the noteworthy amount of debt it has converted into equity over the past 30 days, and upcoming plans for the company. Such plans include the company’s goal to up-list to a national exchange by the end of the year. PBIO is working diligently to meet the necessary requirements to up-list. “Although we are a QB company on the OTC Marketplace, we run the Company as if we were NASDAQ or NYSE-Amex listed. This is important, since we have expectations of moving up to a national stock exchange before the end of this year,” Pressure BioSciences president and CEO Richard T. Schumacher stated in the news release.

To view the full press release, visit http://ibn.fm/HDKaO

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com